Rivaroxaban

Sort by

4-(2-aminophenyl)morpholin-3-one

  • CAT NUMBER DCTI-C-2850
  • CAS NUMBER 1082588-73-5
  • MOLECULAR FORMULA C10H12N2O2
  • MOLECULAR WEIGHT 192.22

4-(3-aminophenyl)morpholin-3-one

  • CAT NUMBER DCTI-C-2849
  • CAS NUMBER 1082495-22-4
  • MOLECULAR FORMULA C10H12N2O2
  • MOLECULAR WEIGHT 192.22

5-chloro-N-methylthiophene-2-carboxamide

  • CAT NUMBER DCTI-C-2747
  • CAS NUMBER 97799-98-9
  • MOLECULAR FORMULA C6H6ClNOS
  • MOLECULAR WEIGHT 175.63

N-Nitroso Rivaroxaban Open-Ring Acid Impurity (Mix...

  • CAT NUMBER DCTI-C-2471
  • CAS NUMBER NA
  • MOLECULAR FORMULA C19H19ClN4O7S
  • MOLECULAR WEIGHT 482.89

Oxazolidine ring open Impurity

  • CAT NUMBER DCTI-C-1580
  • CAS NUMBER 482305-98-6
  • MOLECULAR FORMULA C18H20ClN3O4S
  • MOLECULAR WEIGHT 409.89

Rivaroxaban EP impurity B

  • CAT NUMBER DCTI-C-1916
  • CAS NUMBER 1429334-00-8
  • MOLECULAR FORMULA C16H19N3O5
  • MOLECULAR WEIGHT 333.34

Rivaroxaban EP Impurity D

  • CAT NUMBER DCTI-C-3273
  • CAS NUMBER 1365267-35-1
  • MOLECULAR FORMULA C29H32N6O9
  • MOLECULAR WEIGHT 608.61

Rivaroxaban EP impurity E

  • CAT NUMBER DCTI-C-1917
  • CAS NUMBER 1415566-28-7
  • MOLECULAR FORMULA C19H19N3O5S
  • MOLECULAR WEIGHT 401.44

Rivaroxaban EP impurity F

  • CAT NUMBER DCTI-C-2764
  • CAS NUMBER 24065-33-6
  • MOLECULAR FORMULA C5H3ClO2S
  • MOLECULAR WEIGHT 162.59
LOAD MORE
You're viewed 9 of 24 products

General Information

Rivaroxaban Impurities and Rivaroxaban  

Daicel Pharma provides synthesis for Rivaroxaban impurity standards such as 5-chloro-N-methylthiophene-2-carboxamide, Rivaroxaban impurity B, Rivaroxaban Metabolite 5, Rivaroxaban EP impurity H, Rivaroxaban EP impurity F, Rivaroxaban EP impurity B, RVX III Impurity 5, and more. These impurities are crucial for Rivaroxaban quality, efficiency, safety, and stability. Furthermore, Daicel offers a custom synthesis of Rivaroxaban impurities and delivers them globally according to the client’s requirements.

Rivaroxaban [CAS: 366789-02-8] is a monocarboxylic acid amide and is an anticoagulant. Rivaroxaban is the first orally active direct factor Xa inhibitor. It prevents stroke and venous embolism.

Rivaroxaban: Use and Commercial Availability 

Rivaroxaban prevents venous thromboembolic events (VTE) in patients with total hip or knee replacement surgery; to prevent stroke and systemic embolism in patients with nonvalvular atrial fibrillation; to treat deep vein thrombosis (DVT) and pulmonary embolism (PE); and to reduce the risk of recurrent DVT and or PE. This drug is available under the tradename of Xarelto.

Rivaroxaban Structure and Mechanism of Action Rivaroxaban Structure and Mechanism of Action

The chemical name of Rivaroxaban is 5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide. Its chemical formula is C19H18ClN3O5S, and its molecular weight is approximately 435.9 g/mol.

Rivaroxaban selectively blocks the active site of Factor Xa and helps in the blood coagulation process.

Rivaroxaban Impurities and Synthesis

Rivaroxaban is an anticoagulant medication used to prevent blood clot formation. Like many pharmaceutical compounds, it may contain impurities that can impact its quality and efficacy. They can include related compounds, process-related, and potential genotoxic impurities. The synthesis1 of Rivaroxaban involves a complex multi-step process, including the reaction of various intermediates with reagents, followed by purification steps to isolate the active pharmaceutical ingredient.

Daicel Pharma provides a Certificate of Analysis (CoA) of Rivaroxaban impurity standards such as 5-chloro-N-methylthiophene-2-carboxamide, Rivaroxaban impurity B, Rivaroxaban Metabolite 5, Rivaroxaban EP impurity H, Rivaroxaban EP impurity F, Rivaroxaban EP impurity B, RVX III Impurity 5, and more. Our CoA is from a cGMP-compliant analytical facility and includes comprehensive characterization data, such as 1H NMR, 13C NMR, IR, MASS, and HPLC purity. If requested, we give additional characterization data, such as 13C-DEPT. Daicel Pharma can provide unknown Rivaroxaban impurities or degradation products.

References
FAQ's

Frequently Asked Questions

Comparative research and rigorous quality control ensure that generic versions are equivalent in purity, safety, and efficacy.

During quality control testing, Rivaroxaban impurities use analytical techniques such as HPLC methods to identify and quantify the impurities present in Rivaroxaban.

Due to different synthetic procedures, the level of Rivaroxaban impurities might vary.

Rivaroxaban impurities should be stored at a controlled room temperature between 2-8°C or as indicated on the Certificate of Analysis (CoA).

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart